Skip to main content

Table 3 Stepward forward regression analysis of PAI-1 and metabolic parameters, bone mineral density and therapy

From: Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus

Dependent variable: PAI-1

Beta

p

adjusted R 2

Triglycerides (mmol/L)

0,314

0,0002

0,574

Insulin (mIU/L)

0,250

0,0033

 

Pyrilinks (nMPD/mMc)

−0,308

0,0002

BMI (kg/m2)

0,310

0,0035

Waist circumference (cm)

−0,278

0,0097

Age (years)

−0,364

0,0201

Diabetes duration (years)

−0,187

0,0185

Menopause duration (years)

0,283

0,0688

Beta blockers (%)

0,224

0,0045

 
  1. PAI-1 plasminogen activator inhibitor 1, BMI body mass indeks